Alibaba’s AI cancer detection tool clears FDA hurdle for faster approval process

Alibaba’s AI cancer detection tool clears FDA hurdle for faster approval process

The tech giant’s Damo Academy secured a “breakthrough device” designation from the US regulator for its pancreatic cancer-detecting AI model, Damo Panda.

Alibaba’s AI Tool for Pancreatic Cancer Detection Gains FDA Breakthrough Status

Alibaba Group Holding’s research division, Damo Academy, has received a breakthrough device designation from the US Food and Drug Administration for its AI-powered pancreatic cancer detection model, Damo Panda.